BLT Accelerating the Pace of Opportunity (continued)    

biopharmaceutical development company with the primary mission to bring promising biopharmaceutical products to market, was given the People’s Choice Award. Red Path Integrated Pathology Inc., an early stage diagnostic services company, was selected as the Company Most Likely to Receive Funding.

In addition to the 19 presenting companies, Bio Life Tech welcomed four dynamic featured speakers. Mr. Jeff Singer, Vice President, the NASDAQ Stock Market, offered an inside look at the NASDAQ stock market. Mr. Osagie Imasogie, Co-Founder and Managing Partner, Phoenix IP Ventures, discussed trends in the pharmaceutical industry.
Steve Hurly, Janney Montgomery Scott, discussed the state of the bio industry. Dr. Wise Young, one of the world’s leading neuroscientists, highlighted the developments in stem cell research.

The Bio Life Tech 2005 Venture Conference was successful in matching entrepreneurs with investors, creating new business opportunities in the bio life science industry on the East Coast. Bio Life Tech 2005: Accelerating the Pace of Opportunity.